Related Experiment Video
Updated: Jan 31, 2026
DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
Published on: December 29, 2021
Molecular Characteristics of DNA-Alkylating PI Polyamides Targeting RUNX Transcription Factors
Rina Maeda1, Shinsuke Sato2, Shunsuke Obata2
1Graduate School of Advanced Integrated Studies in Human Survivability , Kyoto University , Sakyo, Kyoto 606-8306 , Japan.
Abstract:
The runt-related transcription factor (RUNX) family has been associated with cancer development. The binding of RUNX family members to specific DNA sequences is hypothesized to promote the expression of downstream genes and cause cancer proliferation. On the basis of this proposed mechanism of cancer growth, we developed conjugate 1, which inhibits the binding of RUNX to its target DNA. Conjugate 1 is a DNA-alkylating pyrrole-imidazole (PI) polyamide conjugate containing chlorambucil as an anticancer agent. Conjugate 1 was reported to have a marked anticancer effect in mouse models of acute myeloid leukemia. Although the effectiveness of 1 has been demonstrated in vivo, the detailed mechanism by which it alkylates DNA is unknown. Here, we chemically elucidated the molecular characteristics of conjugate 1 to confirm its potential as a RUNX-inhibiting drug. We also generated an alternative conjugate 2, which targets the same DNA sequence, by replacing one pyrrole with β-alanine. Comparison of the characteristics of conjugates 1 and 2 suggested that reaction selectivity and binding affinity to the RUNX-binding sequence were improved by the introduction of β-alanine. These findings indicate the possibility of DNA-alkylating PI polyamides as candidates for cancer chemotherapeutics.
Insights
Researchers developed a novel DNA-alkylating drug, conjugate 1, to inhibit RUNX proteins involved in cancer proliferation. Modifications led to conjugate 2, showing improved DNA binding and selectivity for potential cancer therapeutics.
Area of Science:
- Molecular Biology
- Medicinal Chemistry
- Oncology
Background:
- The runt-related transcription factor (RUNX) family is implicated in cancer development by promoting gene expression and cell proliferation.
- Current understanding of how RUNX-inhibiting drugs like conjugate 1 alkylate DNA is limited.
- Pyrrole-imidazole (PI) polyamides are a class of compounds investigated for their potential in cancer treatment.
Purpose of the Study:
- To elucidate the molecular characteristics and DNA alkylation mechanism of conjugate 1, a RUNX-inhibiting drug.
- To synthesize and evaluate an alternative conjugate, conjugate 2, with modifications aimed at improving drug properties.
- To assess the potential of DNA-alkylating PI polyamides as novel cancer chemotherapeutics.
Main Methods:
- Chemical elucidation of the molecular characteristics of conjugate 1.
- Synthesis of conjugate 2, a modified PI polyamide targeting the RUNX-binding DNA sequence.
- Comparative analysis of the reaction selectivity and DNA binding affinity of conjugates 1 and 2.
Main Results:
- The study chemically characterized conjugate 1, confirming its potential as a RUNX inhibitor.
- Conjugate 2, featuring a β-alanine modification, demonstrated enhanced reaction selectivity and binding affinity to the target DNA sequence compared to conjugate 1.
- These findings provide insights into the mechanism of action for DNA-alkylating PI polyamides.
Conclusions:
- DNA-alkylating PI polyamides, such as conjugates 1 and 2, show promise as a new class of anticancer agents.
- Modification of PI polyamides, specifically the introduction of β-alanine, can improve their efficacy in targeting RUNX-binding DNA sequences.
- Further development of these compounds could lead to effective chemotherapeutics for various cancers.
More Related Videos
11:25Enhanced Yeast One-hybrid Screens To Identify Transcription Factor Binding To Human DNA Sequences
Published on: February 11, 2019
06:38High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
Published on: February 7, 2019
Related Concept Videos
02:16Transcription Factors
02:35Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
02:35Transcription Elongation Factors
01:30General Transcription Factors
01:10Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
01:10Factors Affecting α-Alkylation of Ketones: Choice of Base
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence,...